| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoid binding | 2.32e-06 | 48 | 161 | 6 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.63e-06 | 49 | 161 | 6 | GO:0019840 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.71e-06 | 28 | 161 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.52e-05 | 66 | 161 | 6 | GO:0005080 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.61e-05 | 227 | 161 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.80e-05 | 230 | 161 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 ABCA4 ATAD5 NVL RNF213 BTAF1 KATNAL1 DDX50 SMC3 MYH14 HLTF NAV2 POLQ HSPA9 | 1.38e-04 | 614 | 161 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.75e-04 | 35 | 161 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 ABCA4 ATAD5 NVL RNF213 BTAF1 KATNAL1 DDX50 SMC3 NAV2 POLQ HSPA9 | 2.49e-04 | 441 | 161 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | lipid binding | DAB2IP RAPGEF6 ABCA4 UGT1A10 UGT1A8 FFAR3 UGT1A7 ANXA3 GPR42 MBP UGT1A9 NF1 TLN1 PLCB1 PRKCI PARD3 CADPS2 SERPINA5 UNC13A | 3.94e-04 | 988 | 161 | 19 | GO:0008289 |
| GeneOntologyMolecularFunction | cadherin binding | 4.40e-04 | 339 | 161 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 XIRP1 ANK3 TTLL5 MDM1 APC PANX1 KATNAL1 SHROOM4 TTBK1 NF1 SMC3 MYH14 TLN1 FMN2 CTNNA1 CTTN UNC13A MYO16 | 5.55e-04 | 1099 | 161 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | cyclase activity | 9.19e-04 | 24 | 161 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.04e-03 | 25 | 161 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.32e-03 | 7 | 161 | 2 | GO:0005004 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.69e-08 | 5 | 159 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 5.04e-08 | 6 | 159 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 5.04e-08 | 6 | 159 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 5.04e-08 | 6 | 159 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 6.89e-07 | 10 | 159 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 6.89e-07 | 10 | 159 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.30e-06 | 13 | 159 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 4.44e-06 | 5 | 159 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 9.56e-06 | 18 | 159 | 4 | GO:0045760 | |
| GeneOntologyBiologicalProcess | brain development | DAB2IP CACNA1A RPGRIP1L ANXA3 MBP GRID2 MED1 SHROOM4 TTBK1 NF1 SEC16A ASPM PLXNA4 NAV2 PLCB1 CTNNB1 MYO16 PLXNA2 EPHA5 EPHA7 | 1.05e-05 | 859 | 159 | 20 | GO:0007420 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.84e-05 | 21 | 159 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.84e-05 | 21 | 159 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP CACNA1A ANK3 APC GRID2 RHEB NF1 SHANK2 RBMX TLN1 PRKACA PLXNA4 PRKCI CTNNA1 CTNNB1 PARD3 CTTN CDH9 UNC13A EPHA5 EPHA7 | 1.97e-05 | 974 | 159 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | head development | DAB2IP CACNA1A RPGRIP1L ANXA3 MBP GRID2 MED1 SHROOM4 TTBK1 NF1 SEC16A ASPM PLXNA4 NAV2 PLCB1 CTNNB1 MYO16 PLXNA2 EPHA5 EPHA7 | 2.77e-05 | 919 | 159 | 20 | GO:0060322 |
| GeneOntologyBiologicalProcess | liver development | 2.78e-05 | 202 | 159 | 9 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 3.12e-05 | 205 | 159 | 9 | GO:0061008 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.45e-05 | 26 | 159 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.45e-05 | 26 | 159 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | NCAPD3 ZCWPW1 NBN OOEP SMC3 PRKACA MKI67 ASPM PLCB1 FMN2 SGO2 | 8.87e-05 | 350 | 159 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 9.40e-05 | 12 | 159 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MAN2A1 MBP GRID2 RHEB TTBK1 NF1 ASPM PLXNA4 HLTF PRKCI CTNNA1 CTNNB1 PARD3 PLXNA2 EPHA7 | 1.02e-04 | 625 | 159 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.25e-04 | 63 | 159 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.32e-04 | 34 | 159 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | central nervous system development | DAB2IP CACNA1A RPGRIP1L ANXA3 MBP GRID2 MED1 ADAM22 RHEB SHROOM4 TTBK1 NF1 SEC16A ASPM PLXNA4 NAV2 PLCB1 CTNNB1 MYO16 PLXNA2 EPHA5 EPHA7 | 1.33e-04 | 1197 | 159 | 22 | GO:0007417 |
| GeneOntologyBiologicalProcess | centrosome localization | 1.48e-04 | 35 | 159 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 1.48e-04 | 251 | 159 | 9 | GO:2000241 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.65e-04 | 36 | 159 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 1.76e-04 | 3 | 159 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in membrane | 1.76e-04 | 3 | 159 | 2 | GO:0072658 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in plasma membrane | 1.76e-04 | 3 | 159 | 2 | GO:0072660 | |
| GeneOntologyBiologicalProcess | vagus nerve development | 1.76e-04 | 3 | 159 | 2 | GO:0021564 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MAN2A1 MBP RHEB TTBK1 NF1 ASPM PLXNA4 HLTF PRKCI CTNNA1 CTNNB1 PLXNA2 EPHA7 | 1.84e-04 | 515 | 159 | 13 | GO:0050767 |
| GeneOntologyBiologicalProcess | sexual reproduction | NCAPD3 ZCWPW1 TTLL5 NBN OOEP PANX1 KATNAL1 FAM170A SEPTIN2 FSIP2 GMCL2 ROPN1L BCAP31 SMC3 INTS13 PRKACA MKI67 ASPM PLCB1 FMN2 SGO2 CTNNB1 SERPINA5 | 1.85e-04 | 1312 | 159 | 23 | GO:0019953 |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 1.91e-04 | 15 | 159 | 3 | GO:0098908 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.33e-04 | 112 | 159 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP CACNA1A ANK3 GRID2 RHEB NF1 SHANK2 RBMX PLXNA4 CTNNB1 CTTN CDH9 UNC13A EPHA5 EPHA7 | 2.76e-04 | 685 | 159 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell cycle process | DAB2IP NCAPD3 ZCWPW1 ANK3 ATAD5 AHCTF1 MDM1 APC NBN OOEP MED1 KMT2E SEPTIN2 SETDB2 SMC3 INTS13 MKI67 ASPM PLCB1 FMN2 SGO2 PDS5A CTNNB1 MYO16 | 2.84e-04 | 1441 | 159 | 24 | GO:0022402 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.20e-04 | 167 | 159 | 7 | GO:0007043 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 3.51e-04 | 4 | 159 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP PCP4 CACNA1A ANK3 MBP APC GRID2 PDZD7 ADCY6 SEPTIN2 NF1 PLXNA4 PRKCI CTNNA1 CTNNB1 PARD3 CTTN UNC13A MYO16 PLXNA2 EPHA5 EPHA7 | 3.59e-04 | 1285 | 159 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of action potential | 4.09e-04 | 81 | 159 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | SMG1 ZCWPW1 ATAD5 ANXA3 NVL NBN OOEP SMC3 FMN2 PDS5A CTNNB1 POLQ USP1 | 4.41e-04 | 564 | 159 | 13 | GO:0051052 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 5.62e-04 | 132 | 159 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | cellular response to indole-3-methanol | 5.82e-04 | 5 | 159 | 2 | GO:0071681 | |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve development | 5.82e-04 | 5 | 159 | 2 | GO:0021563 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 5.82e-04 | 5 | 159 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | autonomic nervous system development | 5.94e-04 | 50 | 159 | 4 | GO:0048483 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 6.60e-04 | 246 | 159 | 8 | GO:0045216 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.90e-04 | 52 | 159 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | replication fork processing | 6.90e-04 | 52 | 159 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | nuclear transport | 7.22e-04 | 378 | 159 | 10 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 7.22e-04 | 378 | 159 | 10 | GO:0006913 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1A ANKS1B APC GRID2 FAM81A ADAM22 RHEB NF1 SHANK2 KCNC4 RBMX PRKACA PLXNA4 PLCB1 PRKCI CTNNB1 CADPS2 CTTN CDH9 UNC13A EPHA7 | 1.07e-06 | 817 | 159 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | apical junction complex | 2.88e-05 | 158 | 159 | 8 | GO:0043296 | |
| GeneOntologyCellularComponent | adherens junction | 3.66e-05 | 212 | 159 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 DCHS2 XIRP1 RPGRIP1L ANK3 APC PANX1 SHROOM4 TLN1 PRKCI CTNNA1 CTNNB1 PARD3 CDH9 EPHA5 | 4.72e-05 | 591 | 159 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | axon | DAB2IP PCP4 ANK3 ANXA3 MBP APC ARMCX3 ADAM22 NF1 SHANK2 KCNC4 MYH14 TAC1 PARD3 CTTN CDH9 UNC13A UNC80 EPHA5 | 4.91e-05 | 891 | 159 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A ANK3 GRID2 ADAM22 GPR179 SHANK2 KCNC4 CTNNB1 CADPS2 USP48 CDH9 EPHA7 | 6.55e-05 | 405 | 159 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | supramolecular fiber | PCP4 MYH1 KRT6A MYH4 KRT6B RPGRIP1L ANK3 CEP162 TTLL5 MDM1 APC KATNAL1 RYR3 SEPTIN2 SHROOM4 SHANK2 KRT6C MYH14 ASPM FMN2 CTNNB1 CTTN | 8.82e-05 | 1179 | 159 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | postsynapse | CACNA1A ANK3 ANKS1B APC GRID2 FAM81A ADAM22 GPR179 RHEB SHANK2 KCNC4 RBMX PRKACA PLCB1 CTNNB1 CADPS2 CTTN USP48 CDH9 EPHA7 | 9.52e-05 | 1018 | 159 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | dendrite | DAB2IP CACNA1A ANK3 ANXA3 ANKS1B APC GRID2 GPR179 RHEB NF1 SHANK2 KCNC4 PRKACA CTNNB1 CTTN CDH9 EPHA5 EPHA7 | 9.65e-05 | 858 | 159 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | supramolecular polymer | PCP4 MYH1 KRT6A MYH4 KRT6B RPGRIP1L ANK3 CEP162 TTLL5 MDM1 APC KATNAL1 RYR3 SEPTIN2 SHROOM4 SHANK2 KRT6C MYH14 ASPM FMN2 CTNNB1 CTTN | 9.73e-05 | 1187 | 159 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | catenin complex | 9.82e-05 | 32 | 159 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP CACNA1A ANK3 ANXA3 ANKS1B APC GRID2 GPR179 RHEB NF1 SHANK2 KCNC4 PRKACA CTNNB1 CTTN CDH9 EPHA5 EPHA7 | 9.94e-05 | 860 | 159 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A ANK3 GRID2 ADAM22 GPR179 SHANK2 KCNC4 SYDE2 CTNNB1 CADPS2 USP48 CDH9 UNC13A EPHA7 | 1.52e-04 | 583 | 159 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP CACNA1A ANK3 ANXA3 MBP ANKS1B APC GRID2 GPR179 RHEB TTBK1 NF1 SHANK2 KCNC4 PRKACA TAC1 CTNNB1 PARD3 CTTN CDH9 EPHA5 EPHA7 | 1.58e-04 | 1228 | 159 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | intercalated disc | 1.69e-04 | 68 | 159 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | Scrib-APC-beta-catenin complex | 1.72e-04 | 3 | 159 | 2 | GO:0034750 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 3.42e-04 | 4 | 159 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | internode region of axon | 3.42e-04 | 4 | 159 | 2 | GO:0033269 | |
| GeneOntologyCellularComponent | bicellular tight junction | 5.04e-04 | 131 | 159 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | compact myelin | 5.19e-04 | 21 | 159 | 3 | GO:0043218 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ANK3 ANKS1B GRID2 FAM81A ADAM22 RHEB SHANK2 RBMX PLXNA4 CTNNB1 CDH9 EPHA7 | 6.79e-04 | 523 | 159 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | tight junction | 6.88e-04 | 139 | 159 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 7.61e-04 | 94 | 159 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | centrosome | FAM184A RAPGEF6 RPGRIP1L CEP162 TTLL5 MDM1 ANKS1B ANKRD26 APC KATNAL1 KMT2E PRKACA ASPM CTNNB1 LRIF1 | 8.10e-04 | 770 | 159 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | PAR polarity complex | 8.45e-04 | 6 | 159 | 2 | GO:0120157 | |
| GeneOntologyCellularComponent | myosin filament | 8.78e-04 | 25 | 159 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin complex | 1.06e-03 | 59 | 159 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | asymmetric synapse | ANK3 ANKS1B GRID2 FAM81A ADAM22 RHEB SHANK2 RBMX PLXNA4 CTNNB1 EPHA7 | 1.09e-03 | 477 | 159 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | mitotic cohesin complex | 1.18e-03 | 7 | 159 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | myosin II complex | 1.23e-03 | 28 | 159 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 DCHS2 XIRP1 RPGRIP1L ANK3 APC PANX1 SHROOM4 TLN1 PRKCI CTNNA1 CTNNB1 PARD3 CTTN CDH9 HSPA9 EPHA5 | 1.25e-03 | 976 | 159 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.27e-03 | 276 | 159 | 8 | GO:0000775 | |
| GeneOntologyCellularComponent | myelin sheath | 1.39e-03 | 217 | 159 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | PCP4 KRT6A KRT6B RPGRIP1L CEP162 TTLL5 MDM1 APC KATNAL1 SEPTIN2 SHROOM4 SHANK2 KRT6C ASPM FMN2 CTTN | 1.40e-03 | 899 | 159 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | chromosomal region | 1.47e-03 | 421 | 159 | 10 | GO:0098687 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.67e-03 | 112 | 159 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 1.70e-03 | 67 | 159 | 4 | GO:0098686 | |
| GeneOntologyCellularComponent | microtubule organizing center | FAM184A RAPGEF6 RPGRIP1L CEP162 TTLL5 MDM1 ANKS1B ANKRD26 APC EVC KATNAL1 KMT2E PRKACA ASPM CTNNB1 LRIF1 | 1.75e-03 | 919 | 159 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | cell cortex | 2.19e-03 | 371 | 159 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | postsynaptic density | ANK3 ANKS1B GRID2 FAM81A ADAM22 RHEB SHANK2 RBMX CTNNB1 EPHA7 | 2.43e-03 | 451 | 159 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | flotillin complex | 2.49e-03 | 10 | 159 | 2 | GO:0016600 | |
| GeneOntologyCellularComponent | cohesin complex | 3.02e-03 | 11 | 159 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | cilium | ABCA4 RPGRIP1L CEP162 TTLL5 MDM1 EVC PDZD7 ADCY6 SEPTIN2 FSIP2 DNAAF5 ROPN1L SHANK2 PRKACA USP48 | 3.60e-03 | 898 | 159 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | non-motile cilium | 3.93e-03 | 196 | 159 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 4.24e-03 | 13 | 159 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 4.24e-03 | 13 | 159 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | fascia adherens | 4.24e-03 | 13 | 159 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | nuclear matrix | 4.38e-03 | 140 | 159 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 XIRP1 ANKRD26 SEPTIN2 SHROOM4 MYH14 FMN2 CTNNA1 CTTN MYO16 | 4.67e-03 | 576 | 159 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | main axon | 4.77e-03 | 89 | 159 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | neurofilament | 4.93e-03 | 14 | 159 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ANK3 ANKS1B GRID2 FAM81A ADAM22 RHEB SHANK2 RBMX CTNNB1 EPHA7 | 5.24e-03 | 503 | 159 | 10 | GO:0099572 |
| Domain | ARM-type_fold | SMG1 NCAPD3 BZW2 APC CTIF BTAF1 TRIP12 ARMCX3 RYR3 DNAAF5 NF1 ASPM PDS5A CTNNB1 HEATR3 | 2.34e-07 | 339 | 160 | 15 | IPR016024 |
| Domain | - | NCAPD3 APC BTAF1 TRIP12 ARMCX3 DNAAF5 NF1 ASPM PDS5A CTNNB1 HEATR3 | 3.44e-06 | 222 | 160 | 11 | 1.25.10.10 |
| Domain | ARM-like | SMG1 NCAPD3 APC BTAF1 TRIP12 ARMCX3 DNAAF5 NF1 ASPM PDS5A CTNNB1 HEATR3 | 3.77e-06 | 270 | 160 | 12 | IPR011989 |
| Domain | Myosin-like_IQ_dom | 1.82e-05 | 19 | 160 | 4 | IPR027401 | |
| Domain | - | 1.82e-05 | 19 | 160 | 4 | 4.10.270.10 | |
| Domain | UDPGT | 2.77e-05 | 21 | 160 | 4 | PF00201 | |
| Domain | UDPGT | 2.77e-05 | 21 | 160 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 2.77e-05 | 21 | 160 | 4 | IPR002213 | |
| Domain | HEAT_REPEAT | 3.00e-05 | 70 | 160 | 6 | PS50077 | |
| Domain | RBM1CTR | 3.35e-05 | 8 | 160 | 3 | PF08081 | |
| Domain | RBM1CTR | 3.35e-05 | 8 | 160 | 3 | IPR012604 | |
| Domain | P-loop_NTPase | MYH1 MYH4 ABCA4 ATAD5 NVL RNF213 BTAF1 KATNAL1 RHEB SEPTIN2 GIMAP8 DDX50 SMC3 MYH14 ASPM HLTF NAV2 POLQ MYO16 | 1.22e-04 | 848 | 160 | 19 | IPR027417 |
| Domain | IQ | 1.48e-04 | 93 | 160 | 6 | PS50096 | |
| Domain | Myosin_N | 2.60e-04 | 15 | 160 | 3 | PF02736 | |
| Domain | Myosin_N | 2.60e-04 | 15 | 160 | 3 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 3.05e-04 | 38 | 160 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.05e-04 | 38 | 160 | 4 | PS51456 | |
| Domain | Myosin_head | 3.05e-04 | 38 | 160 | 4 | PF00063 | |
| Domain | MYSc | 3.05e-04 | 38 | 160 | 4 | SM00242 | |
| Domain | GPR40-rel_orph | 4.33e-04 | 4 | 160 | 2 | IPR013312 | |
| Domain | Myosin_tail_1 | 4.58e-04 | 18 | 160 | 3 | PF01576 | |
| Domain | Myosin_tail | 4.58e-04 | 18 | 160 | 3 | IPR002928 | |
| Domain | Ank_2 | 5.41e-04 | 215 | 160 | 8 | PF12796 | |
| Domain | IQ | 6.57e-04 | 81 | 160 | 5 | SM00015 | |
| Domain | DUF1041 | 7.17e-04 | 5 | 160 | 2 | SM01145 | |
| Domain | HEAT | 7.53e-04 | 48 | 160 | 4 | PF02985 | |
| Domain | Rho_GTPase_activation_prot | 9.58e-04 | 88 | 160 | 5 | IPR008936 | |
| Domain | RRM_1 | 9.63e-04 | 23 | 160 | 3 | SM00361 | |
| Domain | RRM_dom_euk | 9.63e-04 | 23 | 160 | 3 | IPR003954 | |
| Domain | IQ_motif_EF-hand-BS | 1.06e-03 | 90 | 160 | 5 | IPR000048 | |
| Domain | Keratin_2_head | 1.09e-03 | 24 | 160 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.09e-03 | 24 | 160 | 3 | PF16208 | |
| Domain | - | 1.36e-03 | 248 | 160 | 8 | 1.25.40.20 | |
| Domain | Keratin_II | 1.39e-03 | 26 | 160 | 3 | IPR003054 | |
| Domain | ANK | 1.47e-03 | 251 | 160 | 8 | SM00248 | |
| Domain | Munc13_1 | 1.49e-03 | 7 | 160 | 2 | IPR014770 | |
| Domain | Vinculin/catenin | 1.49e-03 | 7 | 160 | 2 | IPR006077 | |
| Domain | MHD1 | 1.49e-03 | 7 | 160 | 2 | PS51258 | |
| Domain | DUF1041 | 1.49e-03 | 7 | 160 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.49e-03 | 7 | 160 | 2 | IPR010439 | |
| Domain | AAA | 1.52e-03 | 144 | 160 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.52e-03 | 144 | 160 | 6 | IPR003593 | |
| Domain | HEAT | 1.54e-03 | 58 | 160 | 4 | IPR000357 | |
| Domain | ANK_REPEAT | 1.55e-03 | 253 | 160 | 8 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.58e-03 | 254 | 160 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.58e-03 | 254 | 160 | 8 | PS50297 | |
| Domain | FHA | 1.73e-03 | 28 | 160 | 3 | SM00240 | |
| Domain | Ankyrin_rpt | 1.92e-03 | 262 | 160 | 8 | IPR002110 | |
| Domain | FHA_DOMAIN | 2.33e-03 | 31 | 160 | 3 | PS50006 | |
| Domain | FHA | 2.33e-03 | 31 | 160 | 3 | PF00498 | |
| Domain | Plexin_cytopl | 2.52e-03 | 9 | 160 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.52e-03 | 9 | 160 | 2 | IPR013548 | |
| Domain | Plexin | 2.52e-03 | 9 | 160 | 2 | IPR031148 | |
| Domain | SAM_1 | 2.76e-03 | 68 | 160 | 4 | PF00536 | |
| Domain | C2_dom | 2.92e-03 | 164 | 160 | 6 | IPR000008 | |
| Domain | AAA | 3.04e-03 | 34 | 160 | 3 | PS00674 | |
| Domain | IQ | 3.23e-03 | 71 | 160 | 4 | PF00612 | |
| Domain | Ank | 3.55e-03 | 228 | 160 | 7 | PF00023 | |
| Domain | - | 3.58e-03 | 36 | 160 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 3.58e-03 | 36 | 160 | 3 | IPR000253 | |
| Domain | ARM_REPEAT | 4.83e-03 | 40 | 160 | 3 | PS50176 | |
| Domain | - | ABCA4 ATAD5 NVL RNF213 BTAF1 KATNAL1 RHEB SEPTIN2 GIMAP8 DDX50 SMC3 HLTF NAV2 POLQ | 4.96e-03 | 746 | 160 | 14 | 3.40.50.300 |
| Domain | C2 | 5.43e-03 | 131 | 160 | 5 | PF00168 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.20e-03 | 14 | 160 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.20e-03 | 14 | 160 | 2 | PS00790 | |
| Domain | RasGAP | 6.20e-03 | 14 | 160 | 2 | SM00323 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.20e-03 | 14 | 160 | 2 | IPR001426 | |
| Domain | EphA2_TM | 6.20e-03 | 14 | 160 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.20e-03 | 14 | 160 | 2 | IPR001090 | |
| Domain | Eph_TM | 6.20e-03 | 14 | 160 | 2 | IPR027936 | |
| Domain | EPH_lbd | 6.20e-03 | 14 | 160 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 6.20e-03 | 14 | 160 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.20e-03 | 14 | 160 | 2 | IPR016257 | |
| Domain | EPH_LBD | 6.20e-03 | 14 | 160 | 2 | PS51550 | |
| Domain | RasGAP_CS | 6.20e-03 | 14 | 160 | 2 | IPR023152 | |
| Domain | C2 | 6.54e-03 | 137 | 160 | 5 | SM00239 | |
| Domain | SAM | 6.93e-03 | 88 | 160 | 4 | SM00454 | |
| Domain | RasGAP | 7.12e-03 | 15 | 160 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 7.12e-03 | 15 | 160 | 2 | PS00509 | |
| Domain | - | 7.12e-03 | 15 | 160 | 2 | 1.25.40.180 | |
| Domain | MIF4-like | 7.12e-03 | 15 | 160 | 2 | IPR016021 | |
| Domain | RAS_GTPASE_ACTIV_2 | 7.12e-03 | 15 | 160 | 2 | PS50018 | |
| Domain | PDZ | 7.37e-03 | 141 | 160 | 5 | PF00595 | |
| Domain | C2 | 7.59e-03 | 142 | 160 | 5 | PS50004 | |
| Domain | Armadillo | 7.59e-03 | 47 | 160 | 3 | IPR000225 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.67e-05 | 132 | 120 | 8 | M11355 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.24e-05 | 22 | 120 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.65e-05 | 24 | 120 | 4 | MM14599 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 4.87e-05 | 9 | 120 | 3 | MM15030 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 5.25e-05 | 48 | 120 | 5 | MM15069 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.50e-05 | 25 | 120 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 5.50e-05 | 25 | 120 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.50e-05 | 25 | 120 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 6.46e-05 | 26 | 120 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 8.73e-05 | 28 | 120 | 4 | M19580 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.90e-04 | 34 | 120 | 4 | M42555 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.04e-04 | 14 | 120 | 3 | M39328 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 2.04e-04 | 14 | 120 | 3 | M7578 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.54e-04 | 15 | 120 | 3 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.11e-04 | 16 | 120 | 3 | M8516 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.26e-04 | 39 | 120 | 4 | MM15695 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.89e-04 | 73 | 120 | 5 | MM15126 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 3.96e-04 | 41 | 120 | 4 | M7399 | |
| Pathway | PID_MET_PATHWAY | 5.61e-04 | 79 | 120 | 5 | M48 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.68e-04 | 45 | 120 | 4 | MM15694 | |
| Pubmed | SMG1 RGPD2 MYH1 KRT6A MYH4 KRT6B RBMXL1 ANKS1B ANKRD26 TRIP12 ADCY6 BCAP31 RBMXL2 BBX SHANK2 DDX50 GUCY1A2 KRT6C MYH14 RBMX PRKACA ASPM PLXNA4 NAV2 BOD1L1 ARHGEF4 CADPS2 CTTN POLQ USP1 HSPA9 PLXNA2 | 1.64e-13 | 1442 | 162 | 32 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATAD5 AHCTF1 NVL BTAF1 MED1 TRIP12 FSIP2 SETDB2 NOP58 GTF2F2 BBX SMC3 SLC4A1AP MKI67 HLTF SGO2 PDS5A BOD1L1 USP48 LRIF1 | 9.75e-12 | 608 | 162 | 20 | 36089195 |
| Pubmed | DAB2IP CACNA1A RGPD2 ANK3 UACA TBC1D5 ANKS1B APC FAM81A ADAM22 RHEB SEPTIN2 NF1 SHANK2 PRKACA SEC16A PLCB1 PRKCI CTNNA1 CTNNB1 PARD3 CTTN UNC13A HSPA9 | 2.39e-11 | 963 | 162 | 24 | 28671696 | |
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 2.40e-10 | 19 | 162 | 6 | 17002498 | |
| Pubmed | CACNA1A KRT6A KRT6B ANK3 MBP COPB2 ANKS1B APC ARHGEF17 ADAM22 SEPTIN2 NF1 SHANK2 GUCY1A2 MYH14 RBMX TLN1 PRKACA SEC16A PLXNA4 SLC25A11 CTNNA1 ARHGEF4 CTNNB1 CTTN UNC13A HSPA9 | 6.05e-10 | 1431 | 162 | 27 | 37142655 | |
| Pubmed | TDRD15 RPGRIP1L ANK3 CCDC30 CEP162 ANKRD26 APC RNF213 TRIP12 ARMCX3 BCAP31 BBX DDX50 SYDE2 SEC16A MKI67 PDS5A PARD3 HSPA9 | 4.57e-09 | 777 | 162 | 19 | 35844135 | |
| Pubmed | ANK3 BZW2 AHCTF1 COPB2 ANKRD26 APC SEPTIN2 BCAP31 SMC3 TLN1 SEC16A PDS5A BOD1L1 SLC25A11 CTNNA1 PARD3 CTTN HSPA9 | 6.59e-09 | 708 | 162 | 18 | 39231216 | |
| Pubmed | 6.75e-09 | 6 | 162 | 4 | 32527940 | ||
| Pubmed | 6.75e-09 | 6 | 162 | 4 | 20297805 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP UACA TBC1D5 MBP ANKRD26 PANX1 ADCY6 BCAP31 NF1 NAV2 PLCB1 FMN2 CTNNB1 PARD3 PLXNA2 EPHA7 | 1.19e-08 | 569 | 162 | 16 | 30639242 |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.22e-08 | 17 | 162 | 5 | 20639394 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.57e-08 | 7 | 162 | 4 | 8467709 | |
| Pubmed | 1.57e-08 | 7 | 162 | 4 | 27514509 | ||
| Pubmed | 1.57e-08 | 7 | 162 | 4 | 8464825 | ||
| Pubmed | TDRD15 RGPD2 MYH1 MYH4 KRT6B ANK3 RBMXL1 RNF213 FAM81A RBMXL2 MYH14 RBMX TLN1 SEC16A MKI67 SLC25A11 CTNNA1 CTNNB1 HSPA9 | 1.72e-08 | 844 | 162 | 19 | 25963833 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 RBM10 NVL APC MED1 TRIP12 NF1 DDX50 MYH14 SEC16A MKI67 SGO2 CTNNB1 CTTN | 2.21e-08 | 440 | 162 | 14 | 34244565 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATAD5 RBM10 AHCTF1 NVL NBN MED1 TRIP12 NOP58 GTF2F2 BBX DDX50 SLC4A1AP RBMX SEC16A MKI67 CSTF3 SGO2 PDS5A BOD1L1 CTTN | 2.28e-08 | 954 | 162 | 20 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 RAPGEF6 UACA RBM10 NBN BTAF1 MED1 TRIP12 ADCY6 RBMXL2 NF1 SLC4A1AP RBMX SEC16A MKI67 CTNNA1 PARD3 CTTN | 2.57e-08 | 774 | 162 | 18 | 15302935 |
| Pubmed | 3.13e-08 | 8 | 162 | 4 | 20610558 | ||
| Pubmed | 3.13e-08 | 8 | 162 | 4 | 18052087 | ||
| Pubmed | 3.13e-08 | 8 | 162 | 4 | 17179145 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT6A UACA ATAD5 CNOT10 COPB2 ANKRD26 APC NBN MED1 TRIP12 SEPTIN2 NOP58 MYH14 TLN1 MKI67 SLC25A11 CTTN | 5.60e-08 | 724 | 162 | 17 | 36232890 |
| Pubmed | 5.61e-08 | 9 | 162 | 4 | 22511988 | ||
| Pubmed | ATAD5 ANXA3 COPB2 NVL RNF213 NBN MED1 POLR3F NOP58 GTF2F2 SMC3 INTS13 MKI67 HLTF CSTF3 PDS5A BOD1L1 CTNNB1 CTTN USP48 | 6.17e-08 | 1014 | 162 | 20 | 32416067 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 ATAD5 RBM10 TBC1D5 AHCTF1 ANKRD26 NBN BTAF1 MED1 RHEB SEPTIN2 GTF2F2 DDX50 TLN1 SEC16A MKI67 BOD1L1 CTTN HSPA9 | 8.41e-08 | 934 | 162 | 19 | 33916271 |
| Pubmed | 9.32e-08 | 10 | 162 | 4 | 23642732 | ||
| Pubmed | 9.32e-08 | 10 | 162 | 4 | 11465080 | ||
| Pubmed | 9.32e-08 | 10 | 162 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 9.32e-08 | 10 | 162 | 4 | 22558097 | |
| Pubmed | Association of the APC tumor suppressor protein with catenins. | 9.92e-08 | 3 | 162 | 3 | 8259519 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 29519853 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 12646231 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 29357356 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 12847094 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 22469663 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 7543104 | ||
| Pubmed | 1.02e-07 | 222 | 162 | 10 | 37071664 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBM10 AHCTF1 NVL MED1 TRIP12 SEPTIN2 GTF2F2 BBX DDX50 MKI67 BOD1L1 | 1.03e-07 | 283 | 162 | 11 | 30585729 |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.04e-07 | 168 | 162 | 9 | 30631154 | |
| Pubmed | DAB2IP RPGRIP1L ANK3 BZW2 ATAD5 CEP162 TBC1D5 COPB2 RNF213 NBN DDX50 SLC4A1AP PRKACA SEC16A MKI67 CSTF3 FMN2 PRKCI CTNNA1 USP1 | 1.07e-07 | 1049 | 162 | 20 | 27880917 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RBM10 COPB2 NBN BTAF1 TRIP12 NF1 SMC3 INTS13 RBMX TLN1 HLTF CSTF3 CTNNA1 CTTN USP48 | 1.08e-07 | 582 | 162 | 15 | 20467437 |
| Pubmed | NCAPD3 FAM184A MAN2A1 UACA ATAD5 CNOT10 AHCTF1 APC NBN MED1 GTF2F2 BBX SHANK2 DDX50 SLC4A1AP INTS13 TLN1 PRKACA HLTF CDYL2 CSTF3 PDS5A SLC25A11 PARD3 | 1.30e-07 | 1497 | 162 | 24 | 31527615 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.18e-07 | 12 | 162 | 4 | 20308471 | |
| Pubmed | 2.18e-07 | 12 | 162 | 4 | 19419973 | ||
| Pubmed | 2.18e-07 | 12 | 162 | 4 | 22031545 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.18e-07 | 12 | 162 | 4 | 11434514 | |
| Pubmed | 3.06e-07 | 250 | 162 | 10 | 33536335 | ||
| Pubmed | 3.14e-07 | 13 | 162 | 4 | 16571631 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.14e-07 | 13 | 162 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.14e-07 | 13 | 162 | 4 | 25246029 | |
| Pubmed | RAPGEF6 ANK3 RBM10 AHCTF1 NBN MED1 NOP58 GTF2F2 TLN1 SEC16A BOD1L1 SLC25A11 PARD3 CTTN | 3.30e-07 | 549 | 162 | 14 | 38280479 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT6A RBM10 BTAF1 TRIP12 NOP58 NF1 DDX50 KRT6C SMC3 MYH14 RBMX TLN1 SEC16A MKI67 CSTF3 CTNNA1 CTNNB1 CTTN HSPA9 | 3.43e-07 | 1024 | 162 | 19 | 24711643 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 COPB2 UGT1A9 RNF213 ARHGEF17 TRIP12 GIMAP8 TRPM3 SYDE2 TLN1 PLXNA4 FMN2 PDS5A BOD1L1 HEATR3 | 3.93e-07 | 736 | 162 | 16 | 29676528 |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 24821222 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 29644622 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 19124205 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 17558305 | ||
| Pubmed | ATAD5 CNOT10 CEP162 TTLL5 ANKRD26 NBN MED1 TRIP12 BBX MYH14 TLN1 SEC16A SGO2 USP48 LRIF1 | 3.98e-07 | 645 | 162 | 15 | 25281560 | |
| Pubmed | 4.38e-07 | 14 | 162 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.38e-07 | 14 | 162 | 4 | 10836148 | |
| Pubmed | Mouse Crumbs3 sustains epithelial tissue morphogenesis in vivo. | 4.38e-07 | 14 | 162 | 4 | 26631503 | |
| Pubmed | 4.38e-07 | 14 | 162 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.38e-07 | 14 | 162 | 4 | 14672974 | |
| Pubmed | Mutations in Eml1 lead to ectopic progenitors and neuronal heterotopia in mouse and human. | 4.38e-07 | 14 | 162 | 4 | 24859200 | |
| Pubmed | KRT6B RBMXL1 ATAD5 NBN NOP58 DDX50 SMC3 MYH14 RBMX TLN1 MKI67 SGO2 PDS5A LRIF1 HSPA9 | 4.55e-07 | 652 | 162 | 15 | 31180492 | |
| Pubmed | FAM184A ANK3 UACA ATAD5 AHCTF1 TTLL5 NVL ANKRD26 NBN NOP58 BCAP31 SLC4A1AP TLN1 PRKACA ASPM PRKCI CTNNA1 CTNNB1 PARD3 USP48 SUCO HSPA9 EPHA7 | 4.56e-07 | 1487 | 162 | 23 | 33957083 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SMG1 RBMXL1 CNOT10 NVL RHEB NOP58 NF1 BBX DDX50 MYH14 MKI67 CTNNB1 | 5.63e-07 | 410 | 162 | 12 | 26949251 |
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 5.95e-07 | 15 | 162 | 4 | 30562487 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 CEP162 TBC1D5 ANKRD26 APC ARHGEF17 TRIP12 FSIP2 NF1 SYDE2 SEC16A NAV2 FMN2 PRKCI BOD1L1 ARHGEF4 PARD3 | 6.36e-07 | 861 | 162 | 17 | 36931259 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SMG1 RBM10 BTAF1 NF1 SHANK2 TRPM3 SEC16A CSTF3 HSPA9 UNC80 EPHA5 EPHA7 | 7.25e-07 | 420 | 162 | 12 | 28065597 |
| Pubmed | DAB2IP RAPGEF6 ANK3 UACA ANKRD26 PANX1 SEC16A PLCB1 PRKCI CTNNA1 CTNNB1 PARD3 | 7.44e-07 | 421 | 162 | 12 | 36976175 | |
| Pubmed | DAB2IP CACNA1A APC ADAM22 NF1 SHANK2 PLCB1 FMN2 CTNNA1 CTNNB1 CTTN | 7.79e-07 | 347 | 162 | 11 | 17114649 | |
| Pubmed | Pdx1 regulates pancreas tubulogenesis and E-cadherin expression. | 7.90e-07 | 16 | 162 | 4 | 26657766 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 7.90e-07 | 16 | 162 | 4 | 19414484 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7890674 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 20565459 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 15057901 | ||
| Pubmed | The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. | 9.85e-07 | 5 | 162 | 3 | 16204028 | |
| Pubmed | Asef, a link between the tumor suppressor APC and G-protein signaling. | 9.85e-07 | 5 | 162 | 3 | 10947987 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 11166179 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 20301457 | ||
| Pubmed | 1.21e-06 | 225 | 162 | 9 | 12168954 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | TBC1D5 NBN MED1 SEPTIN2 GTF2F2 DDX50 SLC4A1AP MYH14 TLN1 SEC16A PDS5A CTTN | 1.29e-06 | 444 | 162 | 12 | 34795231 |
| Pubmed | 1.32e-06 | 18 | 162 | 4 | 20056724 | ||
| Pubmed | 1.32e-06 | 18 | 162 | 4 | 19503085 | ||
| Pubmed | 1.32e-06 | 18 | 162 | 4 | 27307230 | ||
| Pubmed | KRT6B MAN2A1 RBMXL1 AHCTF1 COPB2 SEPTIN2 NOP58 TKFC MYH14 RBMX TLN1 SLC25A11 CTNNA1 CTNNB1 HSPA9 | 1.34e-06 | 711 | 162 | 15 | 33022573 | |
| Pubmed | 1.35e-06 | 117 | 162 | 7 | 17145500 | ||
| Pubmed | RAPGEF6 CNOT10 CEP162 TBC1D5 ANKRD26 APC NF1 SMC3 SEC16A PRKCI CTNNB1 PARD3 | 1.36e-06 | 446 | 162 | 12 | 24255178 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.66e-06 | 19 | 162 | 4 | 23281178 | |
| Pubmed | 1.66e-06 | 19 | 162 | 4 | 20619750 | ||
| Pubmed | 1.66e-06 | 19 | 162 | 4 | 27405641 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 11731231 | ||
| Pubmed | Identification and in vivo role of the Armadillo-Legless interaction. | 1.96e-06 | 6 | 162 | 3 | 15294866 | |
| Pubmed | GATOR2 complex-mediated amino acid signaling regulates brain myelination. | 2.07e-06 | 20 | 162 | 4 | 35022234 | |
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 2.07e-06 | 20 | 162 | 4 | 7806582 | |
| Pubmed | 2.07e-06 | 20 | 162 | 4 | 38113115 | ||
| Pubmed | 2.07e-06 | 20 | 162 | 4 | 25147501 | ||
| Pubmed | AHCTF1 COPB2 NVL TRIP12 NOP58 NF1 MYH14 RBMX TLN1 SEC16A MKI67 PDS5A CTNNA1 HSPA9 | 2.54e-06 | 653 | 162 | 14 | 22586326 | |
| Pubmed | 2.55e-06 | 21 | 162 | 4 | 19217427 | ||
| Interaction | C3orf18 interactions | 2.90e-08 | 115 | 161 | 10 | int:C3orf18 | |
| Interaction | EFNA4 interactions | KRT6A NCAPD3 KRT6B BZW2 BTAF1 DNAAF5 NOP58 NF1 KRT6C PDS5A HEATR3 EPHA5 EPHA7 | 6.70e-08 | 239 | 161 | 13 | int:EFNA4 |
| Interaction | H3C3 interactions | ATAD5 AHCTF1 MED1 TRIP12 FSIP2 NOP58 GTF2F2 BBX SMC3 MKI67 HLTF SGO2 PDS5A BOD1L1 USP48 LRIF1 | 2.36e-06 | 495 | 161 | 16 | int:H3C3 |
| Interaction | SMC5 interactions | MYH1 MYH4 ATAD5 RBM10 AHCTF1 NVL NBN MED1 TRIP12 NOP58 GTF2F2 BBX DDX50 SMC3 SLC4A1AP RBMX SEC16A MKI67 CSTF3 SGO2 PDS5A BOD1L1 CTTN | 4.78e-06 | 1000 | 161 | 23 | int:SMC5 |
| Interaction | PARD3 interactions | RAPGEF6 UACA ANKRD26 APC PRKACA PLCB1 PRKCI CTNNA1 CTNNB1 PARD3 EPHA5 EPHA7 | 5.13e-06 | 298 | 161 | 12 | int:PARD3 |
| Interaction | HRAS interactions | DAB2IP RAPGEF6 UACA MBP APC PANX1 ADCY6 RHEB DNAAF5 NF1 ZDHHC23 NAV2 PLCB1 PDS5A PRKCI CTNNA1 CTNNB1 PARD3 PLXNA2 | 5.59e-06 | 725 | 161 | 19 | int:HRAS |
| Interaction | KCNA3 interactions | ANK3 BZW2 AHCTF1 COPB2 ANKRD26 APC RNF213 SEPTIN2 BCAP31 KCNC4 SMC3 TLN1 SEC16A PDS5A BOD1L1 SLC25A11 CTNNA1 PARD3 CTTN POLQ HSPA9 | 6.31e-06 | 871 | 161 | 21 | int:KCNA3 |
| Interaction | NANOG interactions | NCAPD3 KRT6B AHCTF1 NVL NBN TRIP12 NOP58 RBMXL2 SMC3 INTS13 SEC16A HLTF SGO2 CTNNB1 HSPA9 | 7.62e-06 | 481 | 161 | 15 | int:NANOG |
| Interaction | NDC80 interactions | KRT6A KRT6B WDR64 RPGRIP1L UACA RBMXL1 CEP162 TTLL5 ANKRD26 FAM170A ASPM CTTN | 8.17e-06 | 312 | 161 | 12 | int:NDC80 |
| Interaction | SIRT6 interactions | SMG1 RBM10 NVL APC MED1 TRIP12 NF1 DDX50 SMC3 MYH14 SEC16A MKI67 SGO2 PDS5A CTNNB1 CTTN USP48 | 1.19e-05 | 628 | 161 | 17 | int:SIRT6 |
| Interaction | KRT8 interactions | SMG1 MYH1 KRT6A KRT6B RAPGEF6 RPGRIP1L UACA CEP162 AHCTF1 TTLL5 ANKRD26 APC KRT6C SEC16A | 1.27e-05 | 441 | 161 | 14 | int:KRT8 |
| Interaction | PKP2 interactions | RPGRIP1L APC SEC16A MKI67 CTNNA1 KIR2DL1 CTNNB1 PARD3 EPHA5 EPHA7 | 1.38e-05 | 225 | 161 | 10 | int:PKP2 |
| Interaction | YWHAZ interactions | DAB2IP NCAPD3 KRT6B RAPGEF6 RPGRIP1L UACA CEP162 TBC1D5 MBP ANKRD26 APC TRIP12 ADAM22 RHEB FSIP2 NF1 SYDE2 PRKACA NAV2 PRKCI ARHGEF4 CTNNB1 PARD3 USP48 SUCO HSPA9 | 1.70e-05 | 1319 | 161 | 26 | int:YWHAZ |
| Interaction | EFNA1 interactions | 1.90e-05 | 103 | 161 | 7 | int:EFNA1 | |
| Interaction | YAP1 interactions | KRT6A KRT6B RAPGEF6 ANK3 UACA RBM10 AHCTF1 COPB2 MED1 SEPTIN2 GTF2F2 NF1 MYH14 TLN1 SEC16A BOD1L1 SLC25A11 CTNNA1 CTNNB1 PARD3 CTTN HSPA9 MVD | 2.06e-05 | 1095 | 161 | 23 | int:YAP1 |
| Interaction | CPNE8 interactions | 2.15e-05 | 105 | 161 | 7 | int:CPNE8 | |
| Interaction | MEN1 interactions | NCAPD3 RBM10 AHCTF1 NVL RNF213 NBN BTAF1 MED1 ARHGEF17 TRIP12 NOP58 GTF2F2 DDX50 SMC3 MYH14 RBMX MKI67 CSTF3 PDS5A BOD1L1 SLC25A11 CTNNB1 | 2.43e-05 | 1029 | 161 | 22 | int:MEN1 |
| Interaction | ABCA4 interactions | 2.72e-05 | 8 | 161 | 3 | int:ABCA4 | |
| Interaction | ECT2 interactions | RPGRIP1L RBMXL1 NVL ZMAT4 ARHGEF17 TRIP12 SEPTIN2 NOP58 RBMXL2 DDX50 MYH14 RBMX SEC16A MKI67 ASPM BOD1L1 SLC25A11 CTNNB1 PARD3 CTTN | 2.79e-05 | 887 | 161 | 20 | int:ECT2 |
| Interaction | PLCH1 interactions | 2.80e-05 | 74 | 161 | 6 | int:PLCH1 | |
| Interaction | FLOT1 interactions | MAN2A1 ANK3 ANKRD26 APC SEPTIN2 NF1 ZDHHC23 FMN2 BOD1L1 SLC25A11 CTNNA1 ARHGEF4 CTNNB1 PARD3 | 2.89e-05 | 475 | 161 | 14 | int:FLOT1 |
| Interaction | KRT18 interactions | KRT6A KRT6B RPGRIP1L CNOT10 CEP162 AHCTF1 ANKRD26 APC KRT6C RBMX SEC16A SLC25A11 CTNNA1 | 3.33e-05 | 419 | 161 | 13 | int:KRT18 |
| Interaction | PTPN13 interactions | 3.67e-05 | 202 | 161 | 9 | int:PTPN13 | |
| Interaction | RAC1 interactions | DAB2IP NCAPD3 ANK3 TBC1D5 ANKRD26 PANX1 RHEB NF1 DDX50 SYDE2 RBMX PRKACA FMN2 PRKCI SLC25A11 CTNNA1 ARHGEF4 CTNNB1 PARD3 USP48 EPHA5 EPHA7 | 3.97e-05 | 1063 | 161 | 22 | int:RAC1 |
| Interaction | KCTD13 interactions | CACNA1A KRT6A ANK3 MBP COPB2 ANKS1B APC ARHGEF17 ADAM22 SEPTIN2 NF1 SHANK2 GUCY1A2 MYH14 RBMX TLN1 PRKACA SEC16A PLXNA4 SLC25A11 CTNNA1 ARHGEF4 CTNNB1 CTTN UNC13A HSPA9 | 4.36e-05 | 1394 | 161 | 26 | int:KCTD13 |
| Interaction | SLX4 interactions | NCAPD3 RBM10 NVL NBN POLR3F NOP58 GTF2F2 SMC3 RBMX MKI67 PDS5A ZNF518B POLQ LRIF1 HSPA9 | 5.69e-05 | 572 | 161 | 15 | int:SLX4 |
| Interaction | YWHAB interactions | DAB2IP NCAPD3 RAPGEF6 UACA CEP162 TBC1D5 ANKRD26 APC ARHGEF17 TRIP12 ADAM22 TKFC NF1 SYDE2 RBMX NAV2 PRKCI ARHGEF4 PARD3 USP48 SUCO | 5.98e-05 | 1014 | 161 | 21 | int:YWHAB |
| Interaction | MKI67 interactions | SMG1 RBMXL1 CNOT10 NVL RHEB NOP58 NF1 BBX DDX50 SMC3 MYH14 MKI67 ASPM NAV2 PDS5A CTNNB1 | 6.51e-05 | 648 | 161 | 16 | int:MKI67 |
| Interaction | C19orf38 interactions | 6.57e-05 | 86 | 161 | 6 | int:C19orf38 | |
| Interaction | NXF1 interactions | NCAPD3 RAPGEF6 RPGRIP1L RBM10 AHCTF1 EVC ARHGEF17 ADAM22 PPP1R26 DNAAF5 BCAP31 NF1 DPH5 DDX50 RBMX TLN1 PRKACA MKI67 HLTF CDYL2 HERC3 ARHGEF4 CTNNB1 CTTN HSPA9 | 6.59e-05 | 1345 | 161 | 25 | int:NXF1 |
| Interaction | LYN interactions | DAB2IP ANK3 UACA CNOT10 ANKRD26 APC ADAM22 NF1 ZDHHC23 PLCB1 FMN2 CTNNA1 SNAPC1 CTNNB1 PARD3 HSPA9 EPHA7 | 6.63e-05 | 720 | 161 | 17 | int:LYN |
| Interaction | YWHAH interactions | DAB2IP RAPGEF6 RPGRIP1L UACA CEP162 TBC1D5 ANKRD26 APC MED1 ARHGEF17 TRIP12 NF1 SYDE2 SEC16A NAV2 FMN2 PRKCI BOD1L1 ARHGEF4 PARD3 USP48 SUCO | 6.77e-05 | 1102 | 161 | 22 | int:YWHAH |
| Interaction | RAD18 interactions | RBMXL1 RBM10 COPB2 NBN NOP58 SLC4A1AP MYH14 HLTF PDS5A CTNNA1 CTNNB1 CTTN HSPA9 | 8.05e-05 | 457 | 161 | 13 | int:RAD18 |
| Interaction | RHOA interactions | ANK3 RBMXL1 TBC1D5 ANKS1B NVL ANKRD26 PANX1 ARHGEF17 ARMCX3 BCAP31 NF1 DDX50 PRKACA MKI67 FMN2 PRKCI SLC25A11 CTNNA1 ARHGEF4 CTNNB1 PARD3 USP48 EPHA7 | 8.34e-05 | 1199 | 161 | 23 | int:RHOA |
| Interaction | MVD interactions | 9.16e-05 | 57 | 161 | 5 | int:MVD | |
| Interaction | KIF20A interactions | UACA RBMXL1 AHCTF1 COPB2 NVL OOEP NOP58 RBMXL2 DDX50 MYH14 RBMX SEC16A MKI67 HLTF NAV2 BOD1L1 HERC3 CTNNB1 PARD3 CTTN CDH9 | 1.01e-04 | 1052 | 161 | 21 | int:KIF20A |
| Interaction | RHOF interactions | NCAPD3 ANK3 UACA TBC1D5 AHCTF1 ANKRD26 PANX1 RHEB DDX50 PRKACA HLTF FMN2 PRKCI CTNNA1 CTNNB1 PARD3 | 1.01e-04 | 673 | 161 | 16 | int:RHOF |
| Interaction | H3-3A interactions | ATAD5 AHCTF1 NVL BTAF1 MED1 TRIP12 SETDB2 GTF2F2 BBX SMC3 SLC4A1AP MKI67 HLTF PDS5A BOD1L1 USP48 LRIF1 | 1.07e-04 | 749 | 161 | 17 | int:H3-3A |
| Interaction | H3C1 interactions | ANKRD42 ANK3 BZW2 ATAD5 AHCTF1 NBN TRIP12 GTF2F2 BBX SMC3 MYH14 MKI67 NAV2 CDYL2 CSTF3 PDS5A CTNNB1 USP48 LRIF1 | 1.09e-04 | 901 | 161 | 19 | int:H3C1 |
| Interaction | ANKRD28 interactions | 1.18e-04 | 235 | 161 | 9 | int:ANKRD28 | |
| Interaction | RHOG interactions | DAB2IP ANK3 UACA TBC1D5 ANKRD26 PANX1 ARMCX3 BCAP31 DDX50 RBMX FMN2 PRKCI SLC25A11 CTNNA1 CTNNB1 PARD3 HSPA9 EPHA5 EPHA7 | 1.24e-04 | 910 | 161 | 19 | int:RHOG |
| Interaction | UGT1A9 interactions | 1.35e-04 | 13 | 161 | 3 | int:UGT1A9 | |
| Interaction | RAC3 interactions | DAB2IP UACA ANKRD26 PANX1 ARMCX3 NF1 DDX50 RBMX FMN2 PRKCI CTNNA1 CTNNB1 PARD3 EPHA5 EPHA7 | 1.37e-04 | 619 | 161 | 15 | int:RAC3 |
| Interaction | RHOB interactions | DAB2IP RAPGEF6 ANK3 UACA ANKRD26 PANX1 ADCY6 SEPTIN2 NF1 PLCB1 FMN2 PRKCI CTNNA1 CTNNB1 PARD3 HSPA9 EPHA5 EPHA7 | 1.37e-04 | 840 | 161 | 18 | int:RHOB |
| Interaction | MAP1LC3B interactions | ANK3 TBC1D5 ARHGEF17 RHEB DDX50 SMC3 RBMX PRKACA MKI67 PDS5A PRKCI CTNNB1 HSPA9 HEATR3 | 1.41e-04 | 551 | 161 | 14 | int:MAP1LC3B |
| Interaction | TERF2IP interactions | PCP4 ATAD5 AHCTF1 NBN BTAF1 MED1 TRIP12 BBX SLC4A1AP MKI67 PDS5A BOD1L1 USP48 LRIF1 | 1.44e-04 | 552 | 161 | 14 | int:TERF2IP |
| Interaction | YWHAG interactions | DAB2IP RAPGEF6 RPGRIP1L UACA CEP162 TBC1D5 ANKRD26 APC ARHGEF17 TRIP12 TTBK1 NF1 SYDE2 SEC16A NAV2 FMN2 PRKCI BOD1L1 ARHGEF4 PARD3 USP48 SUCO HSPA9 | 1.51e-04 | 1248 | 161 | 23 | int:YWHAG |
| Interaction | PPP1R9B interactions | MYH4 ANK3 MBP ADAM22 SHANK2 SYDE2 RBMX PRKACA NAV2 PLCB1 BOD1L1 SLC25A11 CTNNB1 CTTN HSPA9 | 1.54e-04 | 626 | 161 | 15 | int:PPP1R9B |
| Interaction | NRAS interactions | DAB2IP RAPGEF6 UACA BZW2 TBC1D5 ANKRD26 PANX1 BCAP31 NF1 NAV2 PLCB1 FMN2 PRKCI CTNNB1 LRIF1 EPHA7 | 1.56e-04 | 699 | 161 | 16 | int:NRAS |
| Interaction | ADARB1 interactions | RGPD2 RBM10 AHCTF1 NVL NBN ZMAT4 MED1 SEPTIN2 GTF2F2 BBX DDX50 MKI67 HSPA9 | 1.58e-04 | 489 | 161 | 13 | int:ADARB1 |
| Interaction | CTNNB1 interactions | ABCA4 ANK3 UACA ANKRD26 APC MYH14 RBMX TLN1 SEC16A MKI67 ASPM SLC25A11 CTNNA1 CTNNB1 PARD3 USP48 CDH9 HSPA9 EPHA5 EPHA7 | 1.64e-04 | 1009 | 161 | 20 | int:CTNNB1 |
| Interaction | TSC22D1 interactions | 1.88e-04 | 104 | 161 | 6 | int:TSC22D1 | |
| Interaction | UGT1A8 interactions | 1.89e-04 | 3 | 161 | 2 | int:UGT1A8 | |
| Interaction | OCLN interactions | DAB2IP RAPGEF6 ANK3 UACA ANKRD26 APC PANX1 PRKACA FMN2 CTNNA1 CTNNB1 PARD3 EPHA7 | 1.96e-04 | 500 | 161 | 13 | int:OCLN |
| Interaction | C11orf52 interactions | DAB2IP ANK3 UACA ANKRD26 PLCB1 FMN2 CTNNA1 CTNNB1 PARD3 EPHA7 | 2.07e-04 | 311 | 161 | 10 | int:C11orf52 |
| Interaction | EFNA5 interactions | 2.12e-04 | 68 | 161 | 5 | int:EFNA5 | |
| Interaction | CIT interactions | RBMXL1 UGT1A7 RBM10 AHCTF1 COPB2 NVL RNF213 CTIF MED1 TRIP12 NOP58 RBMXL2 DDX50 SMC3 MYH14 RBMX MKI67 HLTF CSTF3 PDS5A BOD1L1 SLC25A11 CTNNA1 CTNNB1 PARD3 | 2.14e-04 | 1450 | 161 | 25 | int:CIT |
| Interaction | EPHA2 interactions | DAB2IP RAPGEF6 ANK3 UACA ANKRD26 PANX1 NF1 PRKACA SEC16A PLCB1 PRKCI CTNNA1 CTNNB1 PARD3 EPHA5 EPHA7 | 2.15e-04 | 719 | 161 | 16 | int:EPHA2 |
| Interaction | LATS1 interactions | MYH1 KRT6A MYH4 RBM10 ANKRD26 APC NOP58 DDX50 KRT6C MYH14 SEC16A PARD3 | 2.24e-04 | 440 | 161 | 12 | int:LATS1 |
| Interaction | EFNA3 interactions | 2.32e-04 | 108 | 161 | 6 | int:EFNA3 | |
| Interaction | YWHAQ interactions | DAB2IP RAPGEF6 RPGRIP1L UACA CEP162 TBC1D5 ANKRD26 APC MED1 TRIP12 BCAP31 NF1 SYDE2 TLN1 NAV2 PRKCI ARHGEF4 CTNNB1 PARD3 USP48 SUCO | 2.32e-04 | 1118 | 161 | 21 | int:YWHAQ |
| Interaction | CAV1 interactions | RAPGEF6 ANK3 ANXA3 ANKRD26 APC PANX1 ADCY6 BCAP31 NF1 PRKACA FMN2 PRKCI CTNNA1 CTNNB1 PARD3 EPHA7 | 2.32e-04 | 724 | 161 | 16 | int:CAV1 |
| Interaction | PLK1 interactions | DAB2IP NCAPD3 ANK3 CEP162 APC MED1 DNAAF5 SMC3 ASPM CTNNB1 PARD3 USP1 HSPA9 | 2.37e-04 | 510 | 161 | 13 | int:PLK1 |
| Interaction | LRRC31 interactions | 2.49e-04 | 205 | 161 | 8 | int:LRRC31 | |
| Interaction | TNIK interactions | CACNA1A ANK3 APC SHANK2 INTS13 PRKACA CTNNA1 CTNNB1 UNC13A EPHA5 EPHA7 | 2.53e-04 | 381 | 161 | 11 | int:TNIK |
| Interaction | ZNF330 interactions | ATAD5 NVL TRIP12 NOP58 GTF2F2 BBX DDX50 SLC4A1AP RBMX HLTF PDS5A USP48 | 2.54e-04 | 446 | 161 | 12 | int:ZNF330 |
| Interaction | CCDC8 interactions | KRT6A BTAF1 TRIP12 NOP58 NF1 DDX50 SMC3 MYH14 RBMX PRKACA SEC16A MKI67 CTNNA1 CTNNB1 HSPA9 | 2.55e-04 | 656 | 161 | 15 | int:CCDC8 |
| Interaction | ERBIN interactions | 2.88e-04 | 265 | 161 | 9 | int:ERBIN | |
| Interaction | PRC1 interactions | RBMXL1 RBM10 NVL APC ARHGEF17 ZNF750 NOP58 RBMXL2 NF1 DDX50 RBMX MKI67 HLTF PDS5A SLC25A11 CTNNB1 CTTN UNC13A EPHA5 | 2.91e-04 | 973 | 161 | 19 | int:PRC1 |
| Interaction | NAA40 interactions | RAPGEF6 ATAD5 RBM10 TBC1D5 AHCTF1 ANKRD26 NBN BTAF1 MED1 RHEB SEPTIN2 GTF2F2 DDX50 TLN1 SEC16A MKI67 BOD1L1 CTTN HSPA9 | 3.10e-04 | 978 | 161 | 19 | int:NAA40 |
| Interaction | TFF1 interactions | 3.16e-04 | 41 | 161 | 4 | int:TFF1 | |
| Interaction | KIAA1217 interactions | 3.25e-04 | 115 | 161 | 6 | int:KIAA1217 | |
| Interaction | RNF123 interactions | MYH1 MYH4 COPB2 UGT1A9 RNF213 ARHGEF17 TRIP12 GIMAP8 TRPM3 SYDE2 TLN1 PLXNA4 FMN2 PDS5A BOD1L1 USP48 HEATR3 | 3.29e-04 | 824 | 161 | 17 | int:RNF123 |
| Interaction | CDC42 interactions | NCAPD3 ANK3 BZW2 TBC1D5 ANKRD26 PANX1 SEPTIN2 BCAP31 NF1 BBX DDX50 RBMX PRKACA MKI67 FMN2 PRKCI SLC25A11 CTNNA1 ARHGEF4 CTNNB1 PARD3 LRIF1 EPHA5 | 3.50e-04 | 1323 | 161 | 23 | int:CDC42 |
| Interaction | LCK interactions | ANK3 RBMXL1 CNOT10 MBP ANKRD26 NF1 RBMX PRKACA FMN2 CTNNA1 PARD3 HSPA9 | 3.56e-04 | 463 | 161 | 12 | int:LCK |
| Interaction | SCARNA22 interactions | 3.73e-04 | 118 | 161 | 6 | int:SCARNA22 | |
| Interaction | CD70 interactions | 3.82e-04 | 166 | 161 | 7 | int:CD70 | |
| Interaction | TNFSF13B interactions | 3.91e-04 | 119 | 161 | 6 | int:TNFSF13B | |
| Interaction | MCM2 interactions | TDRD15 RGPD2 MYH1 MYH4 KRT6B ANK3 RBMXL1 COPB2 RNF213 FAM81A SMC3 MYH14 RBMX TLN1 SEC16A MKI67 SLC25A11 CTNNA1 CTNNB1 HSPA9 | 4.01e-04 | 1081 | 161 | 20 | int:MCM2 |
| Interaction | CHMP4C interactions | RBMXL1 CEP162 AHCTF1 COPB2 NVL RNF213 NOP58 RBMXL2 DDX50 RBMX SEC16A MKI67 NAV2 CTTN HSPA9 | 4.16e-04 | 687 | 161 | 15 | int:CHMP4C |
| Interaction | CDH15 interactions | 4.41e-04 | 19 | 161 | 3 | int:CDH15 | |
| Interaction | KRT19 interactions | 4.53e-04 | 282 | 161 | 9 | int:KRT19 | |
| Interaction | ZUP1 interactions | 5.07e-04 | 174 | 161 | 7 | int:ZUP1 | |
| Interaction | GYPA interactions | 5.07e-04 | 174 | 161 | 7 | int:GYPA | |
| Interaction | PHTF1 interactions | 5.16e-04 | 20 | 161 | 3 | int:PHTF1 | |
| Interaction | TRIM37 interactions | KRT6A MYH4 KRT6B RPGRIP1L RBM10 TTLL5 COPB2 BCAP31 MYH14 RBMX SEC16A MKI67 CTNNB1 HSPA9 | 5.46e-04 | 630 | 161 | 14 | int:TRIM37 |
| Interaction | PLEKHA5 interactions | 5.51e-04 | 231 | 161 | 8 | int:PLEKHA5 | |
| Interaction | POLR1G interactions | ATAD5 NVL NBN TRIP12 NOP58 GTF2F2 BBX DDX50 SLC4A1AP SGO2 PDS5A USP48 | 5.79e-04 | 489 | 161 | 12 | int:POLR1G |
| Interaction | WWTR1 interactions | RAPGEF6 ANK3 RBM10 AHCTF1 NBN NOP58 TLN1 SEC16A SLC25A11 PARD3 USP1 | 5.98e-04 | 422 | 161 | 11 | int:WWTR1 |
| Interaction | EPHA1 interactions | 6.17e-04 | 235 | 161 | 8 | int:EPHA1 | |
| Cytoband | 2q37 | 8.11e-08 | 31 | 162 | 5 | 2q37 | |
| Cytoband | 5q21-q22 | 7.39e-05 | 4 | 162 | 2 | 5q21-q22 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD42 ANK3 UACA ANKS1B ANKRD26 SHANK2 GABPB2 ANKDD1B MYO16 | 1.36e-05 | 242 | 107 | 9 | 403 |
| GeneFamily | UDP glucuronosyltransferases | 3.67e-05 | 32 | 107 | 4 | 363 | |
| GeneFamily | Myosin heavy chains | 8.71e-05 | 15 | 107 | 3 | 1098 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.01e-04 | 181 | 107 | 7 | 694 | |
| GeneFamily | Keratins, type II | 5.32e-04 | 27 | 107 | 3 | 609 | |
| GeneFamily | Plexins | 1.22e-03 | 9 | 107 | 2 | 683 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.25e-03 | 36 | 107 | 3 | 823 | |
| GeneFamily | Sterile alpha motif domain containing | 1.85e-03 | 88 | 107 | 4 | 760 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.09e-03 | 43 | 107 | 3 | 409 | |
| GeneFamily | PDZ domain containing | 2.10e-03 | 152 | 107 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.01e-03 | 14 | 107 | 2 | 1095 | |
| GeneFamily | AAA ATPases | 3.81e-03 | 53 | 107 | 3 | 413 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 4.99e-03 | 18 | 107 | 2 | 620 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAPGEF6 AHCTF1 APC NBN ARMCX3 GTF2F2 BBX SMC3 SLC4A1AP MKI67 ASPM HLTF SNAPC1 POLQ USP48 SUCO USP1 | 6.56e-07 | 656 | 161 | 17 | M18979 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | DAB2IP CACNA1A FAM184A ANK3 CTIF FAM81A ADAM22 SHANK2 GUCY1A2 PLXNA4 FMN2 MYO16 MVD EPHA5 | 2.08e-06 | 488 | 161 | 14 | M39104 |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 3.96e-06 | 198 | 161 | 9 | M3140 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 AHCTF1 NVL APC NBN CTIF BTAF1 MED1 TRIP12 GTF2F2 BBX SMC3 HLTF PDS5A PRKCI PARD3 SUCO | 2.21e-05 | 856 | 161 | 17 | M4500 |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP | 3.11e-05 | 197 | 161 | 8 | M5964 | |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 3.11e-05 | 197 | 161 | 8 | M7696 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ANK3 BZW2 ANKS1B APC PDZD7 FAM81A SHANK2 PLXNA4 FMN2 TAC1 UNC13A PLXNA2 | 3.24e-05 | 465 | 161 | 12 | M39066 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NCAPD3 AHCTF1 TTLL5 MDM1 NBN NOP58 GABPB2 SMC3 RBMX ASPM HLTF CSTF3 SGO2 POLQ USP1 | 3.65e-05 | 714 | 161 | 15 | M1744 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | RPGRIP1L UACA ATAD5 APC NBN PANX1 PPP1R26 ROPN1L DDX50 GABPB2 ZDHHC23 MKI67 ASPM SGO2 CADPS2 POLQ USP1 | 3.71e-05 | 892 | 161 | 17 | M18120 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | AHCTF1 MBP APC KATNAL1 ARMCX3 RHEB BBX MYH14 HLTF NAV2 PLCB1 FMN2 USP48 SUCO USP1 HSPA9 UNC80 | 7.65e-05 | 946 | 161 | 17 | M39169 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | PCP4 ANK3 CCDC30 CEP162 ANXA3 TTLL5 MBP GRID2 CTIF SETDB2 TKFC NAV2 PLCB1 PRKCI CADPS2 PLXNA2 EPHA7 | 8.58e-05 | 955 | 161 | 17 | M45680 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | FAM184A ATAD5 CEP162 TBC1D5 MDM1 ANKRD26 NOP58 SMC3 MKI67 ASPM PDS5A BOD1L1 POLQ | 4.93e-07 | 311 | 155 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | UACA ATAD5 TBC1D5 MDM1 NVL APC SETDB2 NOP58 BBX SMC3 MYH14 ASPM SGO2 PDS5A PARD3 | 1.87e-06 | 469 | 155 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CACNA1A FAM184A RPGRIP1L ATAD5 CEP162 TBC1D5 ANKRD26 DPH5 SMC3 SLC4A1AP MKI67 ASPM FMN2 PDS5A BOD1L1 CTTN POLQ USP48 PURG EPHA5 | 2.84e-06 | 831 | 155 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ANKRD42 FAM184A ATAD5 AHCTF1 MDM1 ANKRD26 APC NBN BTAF1 POLR3F NOP58 SHANK2 SMC3 SLC4A1AP MYH14 INTS13 MKI67 ASPM ANKDD1B SGO2 PDS5A BOD1L1 ZNF518B USP1 LRIF1 | 4.54e-06 | 1257 | 155 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ANKRD42 FAM184A ATAD5 AHCTF1 MDM1 ANKS1B ANKRD26 APC NBN BTAF1 POLR3F NOP58 SHANK2 GUCY1A2 SMC3 SLC4A1AP MYH14 INTS13 MKI67 ASPM ANKDD1B SGO2 PDS5A BOD1L1 ZNF518B USP1 LRIF1 | 6.79e-06 | 1459 | 155 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 8.56e-05 | 192 | 155 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CACNA1A ANKRD42 FAM184A ATAD5 CEP162 MDM1 ANKRD26 APC CTIF KATNAL1 SMC3 MYH14 RBMX MKI67 ASPM SGO2 BOD1L1 HERC3 USP1 LRIF1 | 9.33e-05 | 1060 | 155 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ATAD5 AHCTF1 NVL ANKRD26 BTAF1 BBX SMC3 ASPM SGO2 PDS5A ZNF518B POLQ USP1 | 1.48e-04 | 532 | 155 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | FAM184A ANK3 ANXA3 SHROOM4 SHANK2 MYH14 NAV2 PRKCI PARD3 CADPS2 PLXNA2 | 1.24e-10 | 191 | 162 | 11 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.75e-08 | 192 | 162 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-08 | 193 | 162 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.67e-08 | 197 | 162 | 9 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-07 | 162 | 162 | 8 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.72e-07 | 183 | 162 | 8 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 184 | 162 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 184 | 162 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 184 | 162 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.57e-07 | 188 | 162 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 4.75e-07 | 189 | 162 | 8 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.15e-07 | 191 | 162 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 5.35e-07 | 192 | 162 | 8 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.35e-07 | 192 | 162 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 6.02e-07 | 195 | 162 | 8 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-07 | 198 | 162 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-07 | 198 | 162 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 6.76e-07 | 198 | 162 | 8 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | Severe-T/NK_proliferative|Severe / Disease group and Cell class | 7.29e-07 | 200 | 162 | 8 | 4723613a9f56bff422fc98722128d57b6adf3c5d | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.29e-07 | 200 | 162 | 8 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.29e-07 | 200 | 162 | 8 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-06 | 163 | 162 | 7 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.80e-06 | 168 | 162 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 175 | 162 | 7 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 175 | 162 | 7 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.84e-06 | 114 | 162 | 6 | 613714fd15ad6d553e63d8538ad53bc1ded6bd6c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-06 | 179 | 162 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 181 | 162 | 7 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.92e-06 | 183 | 162 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 183 | 162 | 7 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 183 | 162 | 7 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 184 | 162 | 7 | 9f8cd5ab5af6c35a1be25d70a125b9a3f4dd667a | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-06 | 185 | 162 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 186 | 162 | 7 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.47e-06 | 186 | 162 | 7 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.47e-06 | 186 | 162 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.87e-06 | 188 | 162 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-06 | 188 | 162 | 7 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.08e-06 | 189 | 162 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.08e-06 | 189 | 162 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.29e-06 | 190 | 162 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 6.51e-06 | 191 | 162 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.51e-06 | 191 | 162 | 7 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.74e-06 | 192 | 162 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.21e-06 | 194 | 162 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 195 | 162 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.46e-06 | 195 | 162 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 196 | 162 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 7.71e-06 | 196 | 162 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 7.71e-06 | 196 | 162 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 198 | 162 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.24e-06 | 198 | 162 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 199 | 162 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 199 | 162 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.51e-06 | 199 | 162 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 199 | 162 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 8.51e-06 | 199 | 162 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 8.51e-06 | 199 | 162 | 7 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.51e-06 | 199 | 162 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.51e-06 | 199 | 162 | 7 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 8.51e-06 | 199 | 162 | 7 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.51e-06 | 199 | 162 | 7 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 8.79e-06 | 200 | 162 | 7 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 8.79e-06 | 200 | 162 | 7 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.79e-06 | 200 | 162 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.79e-06 | 200 | 162 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.79e-06 | 200 | 162 | 7 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.94e-06 | 132 | 162 | 6 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 138 | 162 | 6 | 6b83c434895d82eaf3c222eef27acec76f9c0a77 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 139 | 162 | 6 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-05 | 148 | 162 | 6 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.31e-05 | 156 | 162 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 157 | 162 | 6 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.66e-05 | 160 | 162 | 6 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.66e-05 | 160 | 162 | 6 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-05 | 162 | 162 | 6 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-05 | 162 | 162 | 6 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.96e-05 | 163 | 162 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 164 | 162 | 6 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 164 | 162 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 164 | 162 | 6 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 165 | 162 | 6 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 167 | 162 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 168 | 162 | 6 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 168 | 162 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 169 | 162 | 6 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 169 | 162 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.74e-05 | 170 | 162 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.00e-05 | 172 | 162 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 174 | 162 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.26e-05 | 174 | 162 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-05 | 177 | 162 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 178 | 162 | 6 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-05 | 179 | 162 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 179 | 162 | 6 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-05 | 180 | 162 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-05 | 181 | 162 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.31e-05 | 181 | 162 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.31e-05 | 181 | 162 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| Drug | naringenin chalcone | 1.23e-08 | 5 | 162 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 1.23e-08 | 5 | 162 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 3.66e-08 | 6 | 162 | 4 | ctd:C543211 | |
| Drug | alloin | 3.66e-08 | 6 | 162 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 3.66e-08 | 6 | 162 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 8.50e-08 | 7 | 162 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.69e-07 | 8 | 162 | 4 | ctd:C034890 | |
| Drug | AC1MRQNQ | 3.03e-07 | 9 | 162 | 4 | CID003522271 | |
| Drug | DHPASiU | 3.03e-07 | 9 | 162 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 3.03e-07 | 9 | 162 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 3.03e-07 | 9 | 162 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 3.03e-07 | 9 | 162 | 4 | CID005460873 | |
| Drug | thymoquinone | 3.72e-07 | 40 | 162 | 6 | CID000010281 | |
| Drug | 2,6-dihydroxyanthraquinone | 5.02e-07 | 10 | 162 | 4 | ctd:C034889 | |
| Drug | estradiol-3-glucuronide | 5.20e-07 | 23 | 162 | 5 | CID000066651 | |
| Drug | 4-nitrophenyl)imidazole | 7.84e-07 | 11 | 162 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 7.84e-07 | 11 | 162 | 4 | CID006442661 | |
| Drug | N-OH-DABZ | 1.17e-06 | 12 | 162 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.17e-06 | 12 | 162 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 1.17e-06 | 12 | 162 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 1.17e-06 | 12 | 162 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.17e-06 | 12 | 162 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.17e-06 | 12 | 162 | 4 | CID000276709 | |
| Drug | hydratropic acid | 1.41e-06 | 4 | 162 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 1.41e-06 | 4 | 162 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 1.41e-06 | 4 | 162 | 3 | ctd:C037760 | |
| Drug | 2-hydroxyestrone | 1.68e-06 | 13 | 162 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.68e-06 | 13 | 162 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.68e-06 | 13 | 162 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.68e-06 | 13 | 162 | 4 | CID000000411 | |
| Drug | alizarin | 1.68e-06 | 13 | 162 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 2.34e-06 | 14 | 162 | 4 | CID000119515 | |
| Drug | PCB-61 | 2.34e-06 | 14 | 162 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.17e-06 | 15 | 162 | 4 | CID000040469 | |
| Drug | afloqualone | 3.17e-06 | 15 | 162 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 3.17e-06 | 15 | 162 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.17e-06 | 15 | 162 | 4 | CID000010752 | |
| Drug | bergamottin | 3.17e-06 | 15 | 162 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 3.17e-06 | 15 | 162 | 4 | CID000543743 | |
| Drug | norbuprenorphine | 3.46e-06 | 33 | 162 | 5 | CID000114976 | |
| Drug | isovaleric acid | 3.50e-06 | 5 | 162 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 3.50e-06 | 5 | 162 | 3 | ctd:C012776 | |
| Drug | sodium dodecyl sulfate | 3.98e-06 | 91 | 162 | 7 | CID000008778 | |
| Drug | quercetin-3,4'-diglucoside | 4.20e-06 | 16 | 162 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.20e-06 | 16 | 162 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.20e-06 | 16 | 162 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 5.47e-06 | 17 | 162 | 4 | CID000003573 | |
| Drug | clobestasol propionate | 5.47e-06 | 17 | 162 | 4 | CID000002791 | |
| Drug | 6-hydroxychrysene | 5.47e-06 | 17 | 162 | 4 | CID000037766 | |
| Drug | SC-791 | 6.96e-06 | 6 | 162 | 3 | CID010291510 | |
| Drug | 3-phenylpropionic acid | 6.96e-06 | 6 | 162 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 6.96e-06 | 6 | 162 | 3 | ctd:D007216 | |
| Drug | SureCN12722713 | 6.99e-06 | 18 | 162 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 6.99e-06 | 18 | 162 | 4 | CID000152226 | |
| Drug | Br 2 | 6.99e-06 | 18 | 162 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 6.99e-06 | 18 | 162 | 4 | CID000036614 | |
| Drug | ApApG | 6.99e-06 | 18 | 162 | 4 | CID003081975 | |
| Drug | C1 11-32 | 6.99e-06 | 18 | 162 | 4 | CID000443077 | |
| Drug | C11131 | 6.99e-06 | 18 | 162 | 4 | CID000443076 | |
| Drug | ethoxytriethyleneglycol | 7.55e-06 | 66 | 162 | 6 | CID000008190 | |
| Drug | 9-OH-risperidone | 8.81e-06 | 19 | 162 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 8.81e-06 | 19 | 162 | 4 | CID000091433 | |
| Drug | almokalant | 8.81e-06 | 19 | 162 | 4 | CID003033962 | |
| Drug | buprenorphine hydrochloride solution | 1.04e-05 | 41 | 162 | 5 | CID000002476 | |
| Drug | testosterone glucuronide | 1.04e-05 | 41 | 162 | 5 | CID000108192 | |
| Drug | tectochrysin | 1.09e-05 | 20 | 162 | 4 | CID005281954 | |
| Drug | Olux | 1.09e-05 | 20 | 162 | 4 | CID000032797 | |
| Drug | AC1L1OBF | 1.09e-05 | 20 | 162 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.09e-05 | 20 | 162 | 4 | CID000116545 | |
| Drug | entacapone | 1.09e-05 | 20 | 162 | 4 | ctd:C071192 | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | KRT6B FAM184A CEP162 ARHGEF17 ADAM22 PLCB1 HERC3 SERPINA5 MVD | 1.13e-05 | 195 | 162 | 9 | 6101_DN |
| Drug | L 654969 | 1.18e-05 | 42 | 162 | 5 | CID000005218 | |
| Drug | 2-methoxyestradiol | 1.18e-05 | 42 | 162 | 5 | ctd:C022830 | |
| Drug | 7,8-benzoquinoline | 1.33e-05 | 43 | 162 | 5 | CID000009191 | |
| Drug | estriol-16-glucuronide | 1.34e-05 | 21 | 162 | 4 | CID000122281 | |
| Drug | dulcin | 1.34e-05 | 21 | 162 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.34e-05 | 21 | 162 | 4 | CID000069186 | |
| Drug | erythromycin stearate | 1.48e-05 | 111 | 162 | 7 | CID000012559 | |
| Drug | amonafide | 1.63e-05 | 22 | 162 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 1.63e-05 | 22 | 162 | 4 | CID000053167 | |
| Drug | plumbagin | 1.63e-05 | 22 | 162 | 4 | ctd:C014758 | |
| Drug | glabridin | 1.93e-05 | 8 | 162 | 3 | ctd:C107601 | |
| Drug | amidoxime | 1.97e-05 | 23 | 162 | 4 | CID000465967 | |
| Drug | phenanthridine | 1.97e-05 | 23 | 162 | 4 | CID000009189 | |
| Drug | trifluoperazine | MYH1 MYH4 UGT1A10 UGT1A8 UGT1A7 ANXA3 UGT1A9 ADCY6 MYH14 PRKACA PRKCI | 2.17e-05 | 324 | 162 | 11 | CID000005566 |
| Drug | retigabine | 2.29e-05 | 48 | 162 | 5 | CID000121892 | |
| Drug | AS-3201 | 2.35e-05 | 24 | 162 | 4 | CID000153948 | |
| Drug | campestrol | 2.54e-05 | 49 | 162 | 5 | CID000010134 | |
| Drug | 5-MOP | 2.78e-05 | 25 | 162 | 4 | CID000002355 | |
| Drug | Hymecromone | 2.78e-05 | 25 | 162 | 4 | ctd:D006923 | |
| Drug | AzMC | 2.78e-05 | 25 | 162 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.78e-05 | 25 | 162 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.78e-05 | 25 | 162 | 4 | CID000006796 | |
| Drug | Bhg-(2-1)fuc | 2.78e-05 | 25 | 162 | 4 | CID005287784 | |
| Drug | N-phenylmaleimide | 2.78e-05 | 25 | 162 | 4 | CID000013662 | |
| Drug | Thymol | 3.27e-05 | 26 | 162 | 4 | ctd:D013943 | |
| Drug | nogalonic acid methyl ester | 3.71e-05 | 87 | 162 | 6 | CID000443820 | |
| Drug | DEPC | 3.73e-05 | 53 | 162 | 5 | CID000015357 | |
| Drug | licochalcone A | 3.81e-05 | 27 | 162 | 4 | ctd:C070840 | |
| Drug | diflunisal | 3.81e-05 | 27 | 162 | 4 | CID000003059 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.15e-09 | 5 | 160 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 2.88e-08 | 7 | 160 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 5.73e-08 | 8 | 160 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.03e-07 | 9 | 160 | 4 | EFO_0004570, GO_0009410 | |
| Disease | indole-3-carboxylate measurement | 1.56e-07 | 3 | 160 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.56e-07 | 3 | 160 | 3 | EFO_0022216 | |
| Disease | bilirubin measurement, response to tenofovir | 1.70e-07 | 10 | 160 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.70e-07 | 10 | 160 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.67e-07 | 11 | 160 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 3.98e-07 | 12 | 160 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.98e-07 | 12 | 160 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 5.73e-07 | 13 | 160 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 5.73e-07 | 13 | 160 | 4 | EFO_0802007 | |
| Disease | urate measurement, bone density | DAB2IP WDR64 UGT1A10 UGT1A8 UGT1A7 AHCTF1 UGT1A9 KATNAL1 FSIP2 SEC16A PLXNA4 PLCB1 CTNNA1 CADPS2 MYO16 | 1.55e-06 | 619 | 160 | 15 | EFO_0003923, EFO_0004531 |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.88e-06 | 17 | 160 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 1.88e-06 | 17 | 160 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.40e-06 | 18 | 160 | 4 | EFO_0801382 | |
| Disease | vitamin D measurement | TDRD15 UGT1A10 UGT1A8 UGT1A7 MDM1 UGT1A9 KMT2E SHANK2 USP1 PURG EPHA5 | 2.43e-06 | 336 | 160 | 11 | EFO_0004631 |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 3.09e-06 | 6 | 160 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 4.64e-06 | 21 | 160 | 4 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.54e-05 | 28 | 160 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | urate measurement, spine bone mineral density | 1.60e-05 | 58 | 160 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | xanthurenate measurement | 1.78e-05 | 29 | 160 | 4 | EFO_0010551 | |
| Disease | indoleacetate measurement | 1.83e-05 | 10 | 160 | 3 | EFO_0021015 | |
| Disease | response to dolutegravir | 2.04e-05 | 30 | 160 | 4 | EFO_0600017 | |
| Disease | fibrolamellar carcinoma (is_implicated_in) | 2.92e-05 | 2 | 160 | 2 | DOID:5015 (is_implicated_in) | |
| Disease | colon adenocarcinoma (implicated_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:234 (implicated_via_orthology) | |
| Disease | X-24588 measurement | 4.30e-05 | 13 | 160 | 3 | EFO_0800898 | |
| Disease | vitamin D deficiency | 4.78e-05 | 37 | 160 | 4 | EFO_0003762 | |
| Disease | testosterone measurement | DCHS2 FAM184A ZCWPW1 ANK3 UGT1A10 UGT1A8 UGT1A7 ANKS1B UGT1A9 ADCY6 SHROOM4 TTBK1 NF1 BBX SLC4A1AP PLCB1 ANKDD1B USP48 MYO16 | 6.58e-05 | 1275 | 160 | 19 | EFO_0004908 |
| Disease | Aberrant Crypt Foci | 8.73e-05 | 3 | 160 | 2 | C1879526 | |
| Disease | Fibromatosis, Aggressive | 8.73e-05 | 3 | 160 | 2 | C0079218 | |
| Disease | hormone measurement | 9.62e-05 | 84 | 160 | 5 | EFO_0004730 | |
| Disease | vitamin D measurement, COVID-19 | 1.46e-04 | 49 | 160 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | Pachyonychia congenita syndrome | 1.74e-04 | 4 | 160 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.74e-04 | 4 | 160 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.74e-04 | 4 | 160 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.74e-04 | 4 | 160 | 2 | C1721007 | |
| Disease | obesity (implicated_via_orthology) | 1.80e-04 | 215 | 160 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 2.13e-04 | 54 | 160 | 4 | C0278883 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.23e-04 | 22 | 160 | 3 | C3711387 | |
| Disease | Pachyonychia Congenita | 2.89e-04 | 5 | 160 | 2 | C0265334 | |
| Disease | Familial Exudative Vitreoretinopathy | 2.89e-04 | 5 | 160 | 2 | C0339539 | |
| Disease | protachykinin-1 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0801934 | |
| Disease | Hepatoblastoma | 4.32e-04 | 6 | 160 | 2 | C0206624 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 4.32e-04 | 6 | 160 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA4 RBM10 APC GRID2 RHEB GMCL2 NF1 GUCY1A2 INTS13 MKI67 CTNNB1 EPHA7 | 4.70e-04 | 702 | 160 | 12 | C0009402 |
| Disease | velopharyngeal dysfunction | 5.48e-04 | 122 | 160 | 5 | EFO_0009336 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 6.03e-04 | 7 | 160 | 2 | DOID:3457 (is_marker_for) | |
| Disease | Large cell carcinoma of lung | 6.91e-04 | 32 | 160 | 3 | C0345958 | |
| Disease | ovarian cancer (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | cognitive function measurement | MAN2A1 CNOT10 TBC1D5 IP6K1 GRID2 KATNAL1 KMT2E RYR3 BBX KCNC4 PLXNA4 PLCB1 PDS5A CTNNB1 CDH9 PURG EPHA5 EPHA7 | 8.09e-04 | 1434 | 160 | 18 | EFO_0008354 |
| Disease | Adenoma, Microcystic | 9.80e-04 | 36 | 160 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 9.80e-04 | 36 | 160 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 9.80e-04 | 36 | 160 | 3 | C0205646 | |
| Disease | Follicular adenoma | 9.80e-04 | 36 | 160 | 3 | C0205647 | |
| Disease | Papillary adenoma | 9.80e-04 | 36 | 160 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 9.80e-04 | 36 | 160 | 3 | C0205651 | |
| Disease | Adenoma | 9.80e-04 | 36 | 160 | 3 | C0001430 | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.03e-03 | 9 | 160 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 1.03e-03 | 9 | 160 | 2 | cv:C2239176 | |
| Disease | apolipoprotein B measurement | TDRD15 DCHS2 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NOP58 NF1 SLC4A1AP ANKDD1B USP1 | 1.03e-03 | 663 | 160 | 11 | EFO_0004615 |
| Disease | bipolar I disorder | 1.05e-03 | 141 | 160 | 5 | EFO_0009963 | |
| Disease | thyroxine measurement | 1.10e-03 | 83 | 160 | 4 | EFO_0005130 | |
| Disease | daytime rest measurement | 1.18e-03 | 295 | 160 | 7 | EFO_0007828 | |
| Disease | Parkinson disease, disease progression measurement | 1.24e-03 | 39 | 160 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.27e-03 | 147 | 160 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | medulloblastoma (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:0110454 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGQEGQDSMSRAKAN | 436 | Q9UPW8 | |
| GGADKQQMDAELRKE | 1911 | O00555 | |
| EVGRDDNSKKIMENS | 436 | Q96QE3 | |
| GGTRIDDGDKTKMTN | 81 | Q9Y6E2 | |
| MKGSNRNKDHSAEGE | 1 | Q8WY36 | |
| DKGEAGAHRNAKETM | 261 | O43310 | |
| NEEAQDLSGGMQRKL | 1056 | P78363 | |
| QMGIDDSSKDNRGTQ | 601 | O43306 | |
| MVNKLAEGAERDGKN | 711 | P35606 | |
| MENGSLDTFLKKNDG | 756 | P54756 | |
| DKGTQEDRRMQGEKG | 891 | Q96L96 | |
| GQAGDASLMELEKRK | 26 | Q9P0K1 | |
| EDGGAEAQSSKDQMR | 271 | Q9NR80 | |
| KSMKGAGTNEDALIE | 101 | P12429 | |
| GGMKDVQTSKAAEHD | 511 | Q9UPS8 | |
| QDMVRKSEQGLGSAE | 556 | Q8NB25 | |
| VARKRKSDGSMEDAN | 571 | Q8IZT6 | |
| RKQNKEKMAEGGSGD | 31 | Q9UH62 | |
| KMGADSNITNKAGER | 291 | Q8N9B4 | |
| FAKGSKRDMASNEGS | 381 | P98175 | |
| DLLMNDRSTGEKNGK | 806 | Q29RF7 | |
| DAKDAARDMNGKSLD | 61 | P38159 | |
| NSGASERDMEKKLSQ | 261 | Q8TBF8 | |
| RQEMARQKSGNEKGE | 806 | O15381 | |
| EENGMETTENGKASR | 691 | Q9NVM9 | |
| KIQRMGAQQDDGSDA | 601 | Q96PE2 | |
| MGKDQELLEAARTGN | 1 | Q7Z6G8 | |
| GADDQKIAAGTLRQM | 226 | Q9H2P9 | |
| NGGKSLSMVDLQDAR | 741 | Q5VWQ8 | |
| GEDSSSAMGVENRAK | 376 | Q9Y2X3 | |
| RNLSDAATKQEGMEG | 386 | P35222 | |
| KKNAAVMDQESAGNR | 271 | P43627 | |
| MGNAAAAKKGSEQES | 1 | P17612 | |
| DAEQRGEMALKDAKN | 411 | P48668 | |
| GEEKEAMNTRESGKA | 231 | P41743 | |
| EMASTSDKGAQGRND | 536 | Q5T3J3 | |
| LDKADETQRDKGQSM | 471 | Q16706 | |
| KMQQGKDDVSLLSEG | 1036 | Q68CZ1 | |
| EKASRKGSFGEMGEQ | 1506 | Q6PRD1 | |
| DAEQRGEMALKDAKN | 411 | P02538 | |
| NMQEEGSKRTDDKSG | 1231 | Q9Y6X6 | |
| MNNAGQLGLSDEKDR | 216 | Q15034 | |
| MEENDQLKKGAAVDG | 151 | P51572 | |
| SGGQKDNEKSLLRMQ | 3371 | Q5CZC0 | |
| ESGRAEQGSQRGEKM | 876 | Q5VYM1 | |
| NGSLTDKKLENNMRG | 426 | O43424 | |
| LKAQMASAGQGKEEA | 1646 | Q7Z406 | |
| MSERQGAGATNGKDK | 1 | P48539 | |
| GDQKEGDRGSKMVSE | 1661 | O75051 | |
| GDQKEGDRGSKMVSE | 1661 | Q9HCM2 | |
| DAEQRGEMALKDAKN | 411 | P04259 | |
| KKLSGSGENTNRAMS | 226 | Q8NGB6 | |
| ESGTEGTAKEAAMKN | 841 | Q9H5P4 | |
| KGDMNNAKLFSDEAA | 311 | Q12996 | |
| NEEEGDRKTGKQAFM | 466 | Q8TC05 | |
| DRKTGKQAFMGEQEK | 471 | Q8TC05 | |
| ATQLGKDSMEELGKA | 161 | Q9BYJ0 | |
| RLGNGNDKKEMNKSD | 306 | Q8IZD2 | |
| QMGEQADGKDSIARQ | 171 | P53602 | |
| EAGGATSAQIEMNKK | 1156 | P12882 | |
| EESGGQKSAKVLMQN | 3171 | P46013 | |
| GMNIDSETKANNGEK | 401 | Q96RD7 | |
| GMKSKESGENSEQAN | 236 | Q13316 | |
| TQGDLGERKMKLNTE | 156 | Q15375 | |
| GGLSKDDIENMVKNA | 551 | P38646 | |
| SMELKEQKGGEEQRA | 306 | O15529 | |
| GAEDKMTSGDVLSNR | 101 | Q9NX62 | |
| KNRMQLSGEGAKTRE | 46 | Q02978 | |
| GKITAIDMDSGKNGQ | 1211 | Q6V1P9 | |
| EAEKMDGAASQGKSS | 166 | Q15382 | |
| MVDDAGAAESQRGKQ | 1 | A6NGQ2 | |
| GSLSQEMAKGEEKLA | 1076 | Q8NFC6 | |
| SAGDSQKDEKENVMR | 761 | Q711Q0 | |
| AGLDSNEMSLQEKKD | 136 | Q7Z4Q2 | |
| DVRKQGDLMKAAAGE | 96 | P35221 | |
| GQENSKGSTSEKDGM | 946 | O14981 | |
| KSLGEQMGIKENDAA | 2396 | O75417 | |
| SEGKMQQVENGLSEK | 271 | P05154 | |
| SMELKEQKGGEEQRA | 306 | O14843 | |
| GAGNLEDFMKNSDNK | 571 | Q8ND71 | |
| MKEKLNGDTEEGFNR | 66 | Q9BQ39 | |
| EGQKEEGSQQNRDMK | 166 | Q5VVM6 | |
| KDMSQEDRKSDGQSR | 2731 | Q12955 | |
| QLSGKDADRFQKHGM | 616 | Q86UW7 | |
| NQNSKGREEMSAKRA | 1121 | Q5TB80 | |
| MGNHAGKRELNAEKA | 1 | P02686 | |
| KMGTRQHGDDASAEK | 226 | Q92551 | |
| RANDNKSMADVLGDG | 1446 | Q8WYP5 | |
| QQESEAGDSGNSKKM | 971 | P57679 | |
| GMSGAEKLQKEQIES | 106 | A6NKP2 | |
| DDSMKLGGNNTSEKA | 336 | Q14527 | |
| IEQGKMDGDKNEQER | 4251 | Q8NDH2 | |
| GATGLRDKAQETMDS | 531 | Q86Y56 | |
| MGNQDGKLKRSAGDA | 1 | Q9NZ56 | |
| QKVAAMNGRKEEGER | 291 | A6NK97 | |
| DNKDNTAGIMTRKDG | 541 | Q9ULB4 | |
| KKNAAVMDQESAGNR | 271 | P43626 | |
| MGTGASEKQAEQKVR | 1 | Q8N813 | |
| MSGGEFQGKREKSDK | 1346 | Q15648 | |
| RQMNGNQEKGDKTDR | 976 | Q8TEW0 | |
| KRMDGRKASGEEQEC | 331 | Q9UJV8 | |
| GEQAKAQDGLKKRMD | 456 | P33402 | |
| KGQDDEVRTLMANGA | 16 | Q8TAK5 | |
| GSSMKGRELEELKDN | 256 | Q5VT97 | |
| MAERGELDLTGAKQN | 1 | P13984 | |
| RDDKGRKNMQDGASD | 161 | Q9BW62 | |
| KAADSGLKRGDQIME | 566 | Q8TEU7 | |
| VMKKGDVEGSQSQDE | 1056 | Q9UQE7 | |
| DAKDAARDMNGKSLD | 61 | Q96E39 | |
| RPGDNEMKKGKSNES | 1491 | B5MCY1 | |
| EKMQNGFSRTLKSGD | 81 | O60934 | |
| GKMANKANTSGDFEK | 1001 | P0DJD1 | |
| NKEDLEGNSMRCGRK | 386 | Q8NEA9 | |
| GGQQAESKQSKREME | 2441 | Q96Q15 | |
| AGRKSSMDGAQNQDD | 1186 | Q8IVL1 | |
| TGMEDAKAIRGSASQ | 401 | Q9NYZ4 | |
| EDGGKAALSQKMRTG | 41 | Q9ULL8 | |
| KKMTLQTGFEQGDRE | 471 | Q562F6 | |
| EAGGATSAQIEMNKK | 1156 | Q9Y623 | |
| DEKDAMVSQLSRGKQ | 1296 | Q9Y623 | |
| EAKAELQRGMSKANS | 1356 | Q9Y623 | |
| MSQGQGKTDEARRLD | 661 | Q5T8A7 | |
| IKDSQNAGKMKGSDN | 76 | Q9H1D9 | |
| DAKAAARDMNGKSLD | 61 | O75526 | |
| KSKTNDGEEKMEGNS | 236 | Q16533 | |
| SARDRAMKESQQGPK | 1221 | Q9UPX8 | |
| AGADQRAKNQDGMSA | 156 | A6NHY2 | |
| NGNGANKKVELSRMS | 2406 | P25054 | |
| KSQNGMENGDAGSEK | 151 | Q8N8U2 | |
| KENGTGNMDEDLLVK | 841 | P42695 | |
| DKGENEAMESSGKRA | 616 | Q9H9A5 | |
| MAAAEEKVGKNEQGE | 321 | Q63HN8 | |
| DSSKAGQRDTEGSKM | 386 | Q32MQ0 | |
| GIDENGRDENTMKNI | 411 | Q96T68 | |
| RMGRKEGQGNSDSDQ | 526 | Q9H0M4 | |
| DDQKESRGRASMADG | 811 | Q5TCY1 | |
| DNAKRMETKGAGVTL | 396 | Q9HAW8 | |
| MVKRKSSEGQEQDGG | 1 | Q8N2C7 | |
| KMGEEEALQSQASSG | 796 | O15027 | |
| ENIDARKNGMIGLSD | 196 | Q96C74 | |
| GVQKDRMDKNASTFE | 311 | Q14247 | |
| SKAMQVKSGGQDQER | 3336 | Q15413 | |
| ADQDSEAMKRLQAAG | 2446 | Q9Y490 | |
| AMLGRNNGESSRKKD | 856 | Q9HCF6 | |
| QETAEKGGGMSKSQE | 16 | A1A519 | |
| EDESAQTGGRKRGMS | 1121 | P21359 | |
| NEDGEAKMNIADTAK | 836 | Q9UBS9 | |
| DNAKRMETKGAGVTL | 396 | O60656 | |
| QEAMKGKISEDSNHG | 1166 | Q9NQ66 | |
| GADMSGSLNNRTTKD | 226 | Q8IYP9 | |
| GRKVTEMEGQAKELS | 606 | Q9BZF9 | |
| RGGRKVENEDMNKDQ | 306 | Q15019 | |
| GADLMNKSRTNAKGA | 436 | Q92609 | |
| GKEISTKMVGSDQRQ | 426 | Q96PF1 | |
| AEATKNMEAGAGRAS | 531 | Q3LXA3 | |
| VDTMLKKGNAQNTDG | 746 | Q14669 | |
| NGKMNGSTLNKDESK | 621 | Q86UV5 | |
| GLMGKRDADSSIEKQ | 66 | P20366 | |
| NTEKQEDSHSGQKGM | 1016 | Q702N8 | |
| RSENGSDADMVDKNK | 61 | Q9H898 | |
| KGNGKRKSDTEFGNM | 266 | O94782 | |
| DNAKRMETKGAGVTL | 396 | Q9HAW7 | |
| DAEMKNLVGSAREKG | 436 | Q6EMB2 | |
| DNAKRMETKGAGVTL | 396 | Q9HAW9 | |
| ERNGTIKMIQGKEDD | 571 | B1ANS9 | |
| RDNGGNSERMVKEKG | 376 | Q9C0D4 | |
| GMIERKRADSKQNGD | 531 | Q03721 | |
| SERKINAGSQDDEMG | 321 | Q9BWU0 |